DEVELOPMENT OF CATHELICIDIN IN LIPOSOME CARRIER USING THIN LAYER HYDRATION METHOD

Authors

  • ANIS YOHANA CHAERUNISAA Faculty of Pharmacy, Universitas Padjadjaran, Jln Raya Bandung Sumedang KM 21, Sumedang 45363, West Java Indonesia
  • MAYANG KUSUMA DEWI Faculty of Pharmacy, Universitas Padjadjaran, Jln Raya Bandung Sumedang KM 21, Sumedang 45363, West Java Indonesia
  • SRIWIDODO Faculty of Pharmacy, Universitas Padjadjaran, Jln Raya Bandung Sumedang KM 21, Sumedang 45363, West Java Indonesia https://orcid.org/0000-0003-3049-8375
  • I. MADE JONI Faculty of Pharmacy, Universitas Padjadjaran, Jln Raya Bandung Sumedang KM 21, Sumedang 45363, West Java Indonesia https://orcid.org/0000-0001-5949-3418
  • REIVA FARAH DWIYANA Faculty of Pharmacy, Universitas Padjadjaran, Jln Raya Bandung Sumedang KM 21, Sumedang 45363, West Java Indonesia https://orcid.org/0000-0001-9350-0239

DOI:

https://doi.org/10.22159/ijap.2022v14i4.44480

Keywords:

Cathelicidin, LIPOSOME, Thin layer method

Abstract

Objective: The purpose of this study was to produce an optimum liposome formulation and to study the effect formulation parameter such as pospholipid amount and hydration time on characteristics of liposome containing Cathelichidin.

Methods: Liposomes were prepared using a thin layer hydration method. Characterization of liposomes included organoleptic, PSA (Particle Size Analyzer) and zeta potential, entrapment efficiency, morphology by TEM (Transmission Electron Microscopy), the chemical interaction by FTIR (Fourier Transform Infrared Spectroscopy), and the stability by using Freeze-Thaw method.

Results: The result of organoleptic test showed that the liposome were in form of milky white dispersion, odorless, without sedimentation. Optimum formula was obtained by making variations of soy oil : cholesterol 10: 0 (F1), 9: 1 (F2), 8: 2 (F3), 7: 3 (F4), and variations in sonication time (10 and 30 minutes). Based on the results, it was found that the optimum sonication time was 30 minutes. F2 and F3 were chosen as the most optimum formulas with particle sizes of 190.3 ± 6.8 nm and 212.9 ± 4.4 nm; polydispersity index of 0.192 ± 0.023 and 0.137 ± 0.022, and zeta potential as much as -38.8 ± 0.6 mV and -34.8 ± 2.0 mV. To the optimum formula, cathelicidin were loaded with hydration time varies of 100 and 120 minutes. Longer hydration time resulted in smaller particle size and higher entrapment efficiency either for F2 or F3. TEM characterization revealed a spherical shape of liposome from optimum formula. The results of FTIR characterization did not show any interaction between the phospholipids of liposome with cathelicidin. The data from the stability test showed good stability for F2 and F3 with a hydration time of 120 minutes, indicated by a p-value > 0.05 which indicated that there was no significant change in the zeta potential for three Freeze Thaw cycles.

Conclusion: Formula of liposom using variation of soy oil: cholesterol 9:1 and 8:2 with hydration time of 120 minutes revealed the best result with good stability for three Freeze Thaw cycles.

Downloads

Download data is not yet available.

References

M. Zanetti, “Cathelicidins, multifunctional peptides of the innate immunity,” Journal of Leukocyte Biology, vol. 75, no. 1, pp. 39–48, Jan. 2004, doi: 10.1189/jlb.0403147.

I. Garcia-Orue et al., “LL37 loaded nanostructured lipid carriers (NLC): A new strategy for the topical treatment of chronic wounds,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 108, pp. 310–316, Nov. 2016, doi: 10.1016/j.ejpb.2016.04.006.

M. Zaiou, V. Nizet, and R. L. Gallo, “Antimicrobial and Protease Inhibitory Functions of the Human Cathelicidin (hCAP18/LL-37) Prosequence,” Journal of Investigative Dermatology, vol. 120, no. 5, pp. 810–816, May 2003, doi: 10.1046/j.1523-1747.2003.12132.x.

Z. Oren and Y. Shai, “Mode of action of linear amphipathic α-helical antimicrobial peptides,” Biopolymers, vol. 47, no. 6, pp. 451–463, 1998, doi: 10.1002/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F.

H. D. Danenberg et al., “Systemic Depletion of Macrophages by Liposomal Bisphosphonates Reduces Neointimal Formation Following Balloon-Injury in the Rat Carotid Artery,” Journal of Cardiovascular Pharmacology, vol. 42, no. 5, pp. 671–679, 2003.

R. E. W. Hancock and H.-G. Sahl, “Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies,” Nature Biotechnology, vol. 24, no. 12, pp. 1551–1557, Dec. 2006, doi: 10.1038/nbt1267.

R. Eckert, “Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development,” Future Microbiology, vol. 6, no. 6, pp. 635–651, Jun. 2011, doi: 10.2217/fmb.11.27.

M. Mahlapuu, J. Håkansson, L. Ringstad, and C. Björn, “Antimicrobial Peptides: An Emerging Category of Therapeutic Agents,” Frontiers in Cellular and Infection Microbiology, vol. 6, pp. 1–12, Dec. 2016, doi: 10.3389/fcimb.2016.00194.

R. Nordström and M. Malmsten, “Delivery systems for antimicrobial peptides,” Advances in Colloid and Interface Science, vol. 242, pp. 17–34, Apr. 2017, doi: 10.1016/j.cis.2017.01.005.

L. D. Gottemukkula and S. Sampathi, “SNEDDS AS LIPID-BASED NANOCARRIER SYSTEMS: CONCEPTS AND FORMULATION INSIGHTS,” International Journal of Applied Pharmaceutics, vol. 14, no. 2. 2022. doi: 10.22159/ijap.2022v14i2.42930.

Md. Asadujjaman and A. U. Mishuk, “NOVEL APPROACHES IN LIPID BASED DRUG DELIVERY SYSTEMS,” Journal of Drug Delivery and Therapeutics, vol. 3, no. 4, 2013, doi: 10.22270/jddt.v3i4.578.

H.-T. Chou et al., “Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,” International Journal of Antimicrobial Agents, vol. 32, no. 2, pp. 130–138, Aug. 2008, doi: 10.1016/j.ijantimicag.2008.04.003.

A. Umerska et al., “Synergistic interactions between antimicrobial peptides derived from plectasin and lipid nanocapsules containing monolaurin as a cosurfactant against Staphylococcus aureus,” International Journal of Nanomedicine, vol. Volume 12, pp. 5687–5699, Aug. 2017, doi: 10.2147/IJN.S139625.

L. Sun, C. Zheng, and T. Webster, “Self-assembled peptide nanomaterials for biomedical applications: promises and pitfalls,” International Journal of Nanomedicine, vol. Volume 12, pp. 73–86, Dec. 2016, doi: 10.2147/IJN.S117501.

L. Wang, C. Hu, and L. Shao, “The antimicrobial activity of nanoparticles: present situation and prospects for the future,” International Journal of Nanomedicine, vol. 12, pp. 1227–1249, Feb. 2017, doi: 10.2147/IJN.S121956.

M. Padmasree and B. A. Vishwanath, “DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED CAPECITABINE LIPOSOMAL FORMULATIONS WITH ANTICANCER ACTIVITY TOWARDS COLON CANCER,” International Journal of Applied Pharmaceutics, vol. 14, no. 2, 2022, doi: 10.22159/ijap.2022v14i2.43658.

Y. Rosenfeld, N. Papo, and Y. Shai, “Endotoxin (Lipopolysaccharide) Neutralization by Innate Immunity Host-Defense Peptides,” Journal of Biological Chemistry, vol. 281, no. 3, pp. 1636–1643, Jan. 2006, doi: 10.1074/jbc.M504327200.

S. Ron-Doitch et al., “Reduced cytotoxicity and enhanced bioactivity of cationic antimicrobial peptides liposomes in cell cultures and 3D epidermis model against HSV,” Journal of Controlled Release, vol. 229, pp. 163–171, May 2016, doi: 10.1016/j.jconrel.2016.03.025.

A. S. Chauhan, K. Pandey, Girijesh, A. Joshi, B. Dubey, and P. Jain, “A review on Ethosome: A novel drug delivery system for topical fungal disease,” The Pharma Innovation Journal, vol. 7, no. 12, pp. 355–362, 2018.

H. C. Korting and M. Schäfer-Korting, Carriers in the topical treatment of skin disease. In Drug delivery. Berlin, Heidelberg.: Springer, 2010.

D. Verma, “Particle size of liposomes influences dermal delivery of substances into skin,” International Journal of Pharmaceutics, vol. 258, no. 1–2, pp. 141–151, Jun. 2003, doi: 10.1016/S0378-5173(03)00183-2.

M. T. C. McCrudden et al., “The Host Defence Peptide LL-37 is Susceptible to Proteolytic Degradation by Wound Fluid Isolated from Foot Ulcers of Diabetic Patients,” International Journal of Peptide Research and Therapeutics, vol. 20, no. 4, pp. 457–464, Dec. 2014, doi: 10.1007/s10989-014-9410-3.

L. Yeo, C. Chaw, and A. Elkordy, “The Effects of Hydration Parameters and Co-Surfactants on Methylene Blue-Loaded Niosomes Prepared by the Thin Film Hydration Method,” Pharmaceuticals, vol. 12, no. 2, p. 46, Mar. 2019, doi: 10.3390/ph12020046.

M. Goniotaki, S. Hatziantoniou, K. Dimas, M. Wagner, and C. Demetzos, “Encapsulation of naturally occurring flavonoids into liposomes: physicochemical properties and biological activity against human cancer cell lines,” Journal of Pharmacy and Pharmacology, vol. 56, no. 10, pp. 1217–1224, Oct. 2004, doi: 10.1211/0022357044382.

S. Sadeghi, H. Bakhshandeh, R. Ahangari Cohan, A. Peirovi, P. Ehsani, and D. Norouzian, “Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37,” International Journal of Nanomedicine, vol. 14, pp. 9777–9792, Dec. 2019, doi: 10.2147/IJN.S230269.

B. Ruozi et al., “AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study,” International Journal of Nanomedicine, vol. 6, pp. 557–563, Mar. 2011, doi: 10.2147/IJN.S14615.

S. el Abbouni, “Microencapsulation of LL-37 Antimicrobial Peptide in PLGA,” 2016.

S. Yang et al., “Preparation and Characterization of Nanoliposomes Entrapping Medium-Chain Fatty Acids and Vitamin C by Lyophilization,” International Journal of Molecular Sciences, vol. 14, no. 10, pp. 19763–19773, Sep. 2013, doi: 10.3390/ijms141019763.

D. C. A. Putri, R. Dwiastuti, M. Marchaban, and A. K. Nugroho, “OPTIMIZATION OF MIXING TEMPERATURE AND SONICATION DURATION IN LIPOSOME PREPARATION,” Journal of Pharmaceutical Sciences and Community, vol. 14, no. 2, pp. 79–85, Nov. 2017, doi: 10.24071/jpsc.142728.

N. Raval, R. Maheshwari, D. Kalyane, S. R. Youngren-Ortiz, M. B. Chougule, and R. K. Tekade, “Importance of Physicochemical Characterization of Nanoparticles in Pharmaceutical Product Development,” in Basic Fundamentals of Drug Delivery, Elsevier, 2019, pp. 369–400. doi: 10.1016/B978-0-12-817909-3.00010-8.

M. Danaei et al., “Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems,” Pharmaceutics, vol. 10, no. 2, p. 57, May 2018, doi: 10.3390/pharmaceutics10020057.

A. Kumar and C. K. Dixit, “Methods for characterization of nanoparticles,” in Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids, Elsevier, 2017, pp. 43–58. doi: 10.1016/B978-0-08-100557-6.00003-1.

A. Pezeshky, B. Ghanbarzadeh, H. Hamishehkar, M. Moghadam, and A. Babazadeh, “Vitamin A palmitate-bearing nanoliposomes: Preparation and characterization,” Food Bioscience, vol. 13, pp. 49–55, Mar. 2016, doi: 10.1016/j.fbio.2015.12.002.

Merck, “IR Spectrum Table by Frequency Range,” 2021. https://www.sigmaaldrich.com/technical-documents/articles/biology/ir-spectrum-table.html

U. Gupta, VivekK. Singh, V. Kumar, and Y. Khajuria, “Spectroscopic Studies of Cholesterol: Fourier Transform Infra-Red and Vibrational Frequency Analysis,” Materials Focus, vol. 3, no. 3, pp. 211–217, Jun. 2014, doi: 10.1166/mat.2014.1161.

A. Barth, “Infrared spectroscopy of proteins,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1767, no. 9, pp. 1073–1101, Sep. 2007, doi: 10.1016/j.bbabio.2007.06.004.

Published

07-06-2022

How to Cite

CHAERUNISAA, A. Y., DEWI, M. K., SRIWIDODO, JONI, I. M., & DWIYANA, R. F. (2022). DEVELOPMENT OF CATHELICIDIN IN LIPOSOME CARRIER USING THIN LAYER HYDRATION METHOD. International Journal of Applied Pharmaceutics, 14(4). https://doi.org/10.22159/ijap.2022v14i4.44480

Issue

Section

Original Article(s)